Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.52 USD | +3.45% | +5.89% | +181.99% |
Mar. 19 | Avidity Biosciences, Inc. announced that it has received $400.208766 million in funding | CI |
Mar. 15 | Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+181.99% | 2.04B | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |
- Stock
- Equities
- Stock Avidity Biosciences, Inc. - Nasdaq
- News Avidity Biosciences, Inc.
- Avidity Biosciences : Receives FDA Clearance for Early Stage Trial of Myotonic Dystrophy Treatment